School of Public Health awarded $30 million to develop and introduce pneumococc...( The Johns Hopkins Bloomberg School of P...)

The Johns Hopkins Bloomberg School of Public is receiving $30 million dollars from the Global Alliance for Vaccines and Immunization (GAVI) and its financing arm, The Vaccine Fund, to accelerate the development and use of life-saving pneumococcal vaccines for children in the world's poorest countries. Through this public health effort, the School and its partners hope to prevent the deaths of nearly 2.2 million children between 2006 and 2020.

According to the World Health Organization, pneumococcal infections kill more than one million children each year, which is the same number that die from malaria. Most are infants and young children who die from pneumonia and meningitis. Immunizations are urgently needed because in many countries, up to 90 percent of pneumococcal strains are resistant to first-line antibiotics. Vaccines tailored to prevent the strains that are most prevalent in developing countries are in advanced stages of large-scale testing in Africa and Asia and should be available by 2006.

"In the past, life-saving vaccines have been slow to reach the children who need them the most. Nearly 15 years after Haemophilus influenzae type b vaccine was introduced in the United States and other rich countries, less than 10 percent of the children in the world's poorest countries receive this vaccine," explained Orin Levine, PhD, an associate with the School's Department of International Health. "Our aim is to work with national and international partners to accelerate this process by 10 years or more," said Dr. Levine.

The Pneumococcal Accelerated Development and Introduction Plan (ADIP) team at the Johns Hopkins Bloomberg School of Public Health, directed by Dr. Levine, will bring together experts from the public and private sectors. The team will coordinate efforts to address research, communications, supply, and financing issues that impede the uptake of the vaccine in developing countries. Establishing the burden of pneumococcal disease and the
'"/>

Contact: Tim Parsons
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
11-Feb-2003

Page: 1 2
Related biology news :

1. White House to honor UNC School of Medicine scientist for early career achievement
2. LSU Vet School receives $9.9 million for infectious disease research
3. Researchers in UGA Vet School discover a mechanism that blocks replication of a retrovirus
4. Dartmouth Medical School awarded $9 million grant for genomics research
5. Research news from Tufts University, Friedman School of Nutrition Science and Policy: February 2004
6. Mount Sinai School of Medicine conducting clinical trials with gene therapy for colorectal cancer
7. Harvard Medical School launches new department to study human biology at the level of whole systems
8. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine
9. Dartmouth Medical School geneticists discover new role for antisense RNA
10. School of public health launches CDC Center for Excellence in Environmental Public Health Tracking
11. Grant from Vetlesen Foundation supports URI Graduate School of Oceanography Climate Research